Combining the advances in neuroscience and modern genetic engineering, CombiGene has developed a therapeutic approach that has demonstrated in preclinical studies that prophylaxis of epilepsy cases is possible. The company is currently working to further develop this treatment to adapt to epilepsy patients.
主要成员
Arne Ferstad、Morten Albrechtsen、Susana Ayesa Alvarez、Peter Nilsson、Lars Thunberg